Volume 26, Number 9—September 2020
Duration of Carbapenemase-Producing Enterobacteriaceae Carriage in Hospital Patients
|Independently performs ADL||12 (57.1)|
|Requires assistance in ADL||4 (19.0)|
|Wheelchair bound||3 (14.3)|
|Colonization or infection with another MDRO in the year preceding enrollment||4 (19.0)|
|Hospitalization in past year||11 (52.4)|
|Antibiotic intake during follow-up period||13 (61.9)|
|Readmission during follow-up period||10 (47.6)|
|Recent overseas travel||13 (61.9)|
*Median age (interquartile range) was 60.0 (50.0–69.0) y; median Charlson Morbidity Index (interquartile range) 3.0 (2.0–5.0). ADL, activities of daily living; MDRO, multidrug-resistant organisms, including methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, carbapenem-resistant Enterobacteriaceae, carbapenem-resistant Acinetobacter baumanii, and carbapenem-resistant Pseudomonas aeruginosa, recorded from surveillance and clinical cultures taken in the year before study enrollment.
†Gastrointestinal surgeries (n = 7), skin and soft tissue surgeries (n = 4), neurosurgery (n = 2), removal of Tenckhoff catheter (n = 1), and urologic procedure (n = 1).
1These authors contributed equally to this article.